Personalized Cancer Vaccines Market Report

Global and China Personalized Cancer Vaccines Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 08, 2022
  • PAGES：149
  • REPORT CODE：GMM1446847
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Personalized Cancer Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Genocea

    • Genetech

    • Merck

    • ISA Pharmaceuticals

    • Celldex

    • Hoffmann-La Roche Ltd

    • Gritstone Oncology

    • Advaxis Inc

    • Personalis

    • Moderna Therapeutics

    • CureVac AG

    • BioNtech

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • By Cancer Type

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Leukemia

    • Prostate Cancer

    • Cervical Cancer

    • Glioblastoma

    • Others

    • By Mechanism of Action Type

    • Tumor-associated antigens (TAAs)

    • Tumor-specific antigens (TSAs)

    • Somatic Mutations in Cancer Pharmacogenomics

    • Pharmacogenomics towards Genomic Polymorphism

    Application:

    • Hospitals

    • Homecare

    • Specialty Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Personalized Cancer Vaccines Industry Overview

      • 1.1.1 Personalized Cancer Vaccines Market Scope and Market Segments

      • 1.1.2 Personalized Cancer Vaccines Industry Characteristics

      • 1.1.3 Global and China Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Personalized Cancer Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Personalized Cancer Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 By Cancer Type

      • 1.2.2 Lung Cancer

      • 1.2.3 Breast Cancer

      • 1.2.4 Colorectal Cancer

      • 1.2.5 Leukemia

      • 1.2.6 Prostate Cancer

      • 1.2.7 Cervical Cancer

      • 1.2.8 Glioblastoma

      • 1.2.9 Others

      • 1.2.10 By Mechanism of Action Type

      • 1.2.11 Tumor-associated antigens (TAAs)

      • 1.2.12 Tumor-specific antigens (TSAs)

      • 1.2.13 Somatic Mutations in Cancer Pharmacogenomics

      • 1.2.14 Pharmacogenomics towards Genomic Polymorphism

    • 1.3 Global Personalized Cancer Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Homecare

      • 1.3.3 Specialty Clinics

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Personalized Cancer Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Personalized Cancer Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Personalized Cancer Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Personalized Cancer Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Personalized Cancer Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Personalized Cancer Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Personalized Cancer Vaccines Industry PEST Analysis

    • 2.3 Personalized Cancer Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Personalized Cancer Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Personalized Cancer Vaccines Industry

    Chapter 3 Global and China Personalized Cancer Vaccines Market, by Manufacturer

    • 3.1 Global and China Personalized Cancer Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Personalized Cancer Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Personalized Cancer Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Personalized Cancer Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Personalized Cancer Vaccines Market Top 3 Players

    Chapter 4 Global and China Personalized Cancer Vaccines Market, by Type (2017-2028)

    • 4.1 Personalized Cancer Vaccines Market Trend, by Type

    • 4.2 Global Personalized Cancer Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Personalized Cancer Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Personalized Cancer Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Personalized Cancer Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Personalized Cancer Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Personalized Cancer Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Personalized Cancer Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Personalized Cancer Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Personalized Cancer Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Personalized Cancer Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Personalized Cancer Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Personalized Cancer Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Personalized Cancer Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Personalized Cancer Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Personalized Cancer Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Personalized Cancer Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Personalized Cancer Vaccines Market Analysis

    • 7.1 North America Personalized Cancer Vaccines Market, by Type

    • 7.2 North America Personalized Cancer Vaccines Market, by Application

    • 7.3 North America Personalized Cancer Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Personalized Cancer Vaccines Market Analysis

    • 8.1 Europe Personalized Cancer Vaccines Market, by Type

    • 8.2 Europe Personalized Cancer Vaccines Market, by Application

    • 8.3 Europe Personalized Cancer Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Personalized Cancer Vaccines Market Analysis

    • 9.1 APAC Personalized Cancer Vaccines Market, by Type

    • 9.2 APAC Personalized Cancer Vaccines Market, by Application

    • 9.3 APAC Personalized Cancer Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Personalized Cancer Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Personalized Cancer Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Personalized Cancer Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Personalized Cancer Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Personalized Cancer Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Personalized Cancer Vaccines Company Profiles

      • 11.1 Genocea

        • 11.1.1 Genocea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Genocea Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.1.3 Genocea Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Genetech

        • 11.2.1 Genetech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Genetech Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.2.3 Genetech Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Merck

        • 11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Merck Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.3.3 Merck Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 ISA Pharmaceuticals

        • 11.4.1 ISA Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 ISA Pharmaceuticals Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.4.3 ISA Pharmaceuticals Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Celldex

        • 11.5.1 Celldex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Celldex Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.5.3 Celldex Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Hoffmann-La Roche Ltd

        • 11.6.1 Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.6.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Gritstone Oncology

        • 11.7.1 Gritstone Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Gritstone Oncology Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.7.3 Gritstone Oncology Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Advaxis Inc

        • 11.8.1 Advaxis Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Advaxis Inc Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.8.3 Advaxis Inc Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Personalis

        • 11.9.1 Personalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Personalis Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.9.3 Personalis Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Moderna Therapeutics

        • 11.10.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Moderna Therapeutics Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.10.3 Moderna Therapeutics Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 CureVac AG

        • 11.11.1 CureVac AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 CureVac AG Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.11.3 CureVac AG Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 BioNtech

        • 11.12.1 BioNtech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 BioNtech Personalized Cancer Vaccines Product Profiles, Application and Specification

        • 11.12.3 BioNtech Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Personalized Cancer Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Personalized Cancer Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Personalized Cancer Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Personalized Cancer Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Personalized Cancer Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of By Cancer Type (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Lung Cancer (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Breast Cancer (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Colorectal Cancer (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Leukemia (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Prostate Cancer (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Cervical Cancer (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Glioblastoma (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of By Mechanism of Action Type (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Tumor-associated antigens (TAAs) (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Tumor-specific antigens (TSAs) (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Somatic Mutations in Cancer Pharmacogenomics (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Pharmacogenomics towards Genomic Polymorphism (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Homecare (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Specialty Clinics (2017-2028)

    • Figure Global Personalized Cancer Vaccines Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Personalized Cancer Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Personalized Cancer Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Personalized Cancer Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Personalized Cancer Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Personalized Cancer Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Personalized Cancer Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Personalized Cancer Vaccines Market Share, by Manufacturer in 2022

    • Table Global Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Value, by Type (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Personalized Cancer Vaccines Price Trend, by Type (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Value, by Type (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Personalized Cancer Vaccines Price Trend, by Type (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Value, by Application (2017-2028)

    • Table Global Personalized Cancer Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Personalized Cancer Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Value, by Application (2017-2028)

    • Table China Personalized Cancer Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Personalized Cancer Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Personalized Cancer Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Personalized Cancer Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Personalized Cancer Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Genocea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genocea Product Profiles, Application and Specification

    • Table Genocea Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genetech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genetech Product Profiles, Application and Specification

    • Table Genetech Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ISA Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ISA Pharmaceuticals Product Profiles, Application and Specification

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celldex Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celldex Product Profiles, Application and Specification

    • Table Celldex Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gritstone Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gritstone Oncology Product Profiles, Application and Specification

    • Table Gritstone Oncology Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Advaxis Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Advaxis Inc Product Profiles, Application and Specification

    • Table Advaxis Inc Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Personalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Personalis Product Profiles, Application and Specification

    • Table Personalis Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Moderna Therapeutics Product Profiles, Application and Specification

    • Table Moderna Therapeutics Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CureVac AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CureVac AG Product Profiles, Application and Specification

    • Table CureVac AG Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioNtech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioNtech Product Profiles, Application and Specification

    • Table BioNtech Personalized Cancer Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US